Connection
Joseph Schacht to Catechol O-Methyltransferase Inhibitors
This is a "connection" page, showing publications Joseph Schacht has written about Catechol O-Methyltransferase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.340 |
|
|
|
-
Schacht JP, Hoffman M, Voronin KE, Book SW, Anton RF. Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone. Neuropsychopharmacology. 2022 10; 47(11):1953-1960.
Score: 0.204
-
Schacht JP. COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review. Pharmacogenomics J. 2016 10; 16(5):430-8.
Score: 0.135